Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Recruiting · NCT06350032 · Registry updated 2025-05-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2025-05-31 | NCT06350032 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AOP Orphan Pharmaceuticals AG | 5 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gottsegen National Cardiovascular Center | Budapest | Hungary | 1 |
| Medizinische Universität Wien | Vienna | Austria | 7 |
| Necker-Enfants Malades Hospital, Paris | Paris | France | 1 |
| Pediatric Cardiac Center | Bratislava | Slovakia | 1 |
| Ramón y Cajal University Hospital | Madrid | Spain | 2 |